Camille Carroll

NIHR Newcastle Biomedical Research Centre — United Kingdom

Medicine · Health Sciences

34h-index4.1kcitations170works10.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(93), Neurological disorders and treatments(39), Autism Spectrum Disorder Research(21), Health Systems, Economic Evaluations, Quality of Life(21), Assistive Technology in Communication and Mobility(13)

Publications169 total

Peripheral and CSF protein quantification in Parkinson’s disease and multiple system atrophy - the Nucleic acid Linked Immuno-Sandwich Assay
Brain Communications·2026Open Access
The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process
Nature Reviews Neurology·2026Open Access
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: Post Hoc Analysis of Two Phase 3 Clinical Trials
Neurology and Therapy·2025Open Access
Validation Of CAM Questionnaire To Access Literacy About Breast Cancer in Brazilian Population – QuIC-Mama
Journal of Cancer Education·2025
Treatment Selection and Prioritization for the <scp>EJS ACT</scp>‐<scp>PD MAMS</scp> Trial Platform
Movement Disorders·2025· 3 citedOpen Access
Barriers and facilitators for digital health medical device registration in the UK: A scoping review
2025Open Access
Sustained Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa in Parkinson’s Disease: 96-week Primary Treatment Period Results from an Ongoing Open-label Extension Study (P11-5.006)
Neurology·2025· 2 cited
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
The Lancet·2025· 85 citedOpen Access
Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping review
Journal of Parkinson s Disease·2025· 2 citedOpen Access
Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson’s disease: the ADepT-PD RCT pilot
Health Technology Assessment·2025Open Access
Digital health technologies and self-efficacy in Parkinson’s: a scoping review
BMJ Open·2025· 2 citedOpen Access
The challenges of implementing change within the Parkinson’s therapy landscape
Advances in Clinical Neuroscience & Rehabilitation·2025Open Access
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
Journal of Parkinson s Disease·2024· 6 citedOpen Access
Accelerating Parkinson’s Disease drug development with federated learning approaches
npj Parkinson s Disease·2024· 15 citedOpen Access
Self-Management Systems for Patients and Clinicians in Parkinson’s Disease Care: A Scoping Review
Journal of Parkinson s Disease·2024· 5 citedOpen Access
Self-Management Systems for Patients and Clinicians in Parkinson Care: Protocol for an Integrated Scoping Review, Product Search, and Evaluation
JMIR Research Protocols·2024· 2 citedOpen Access
Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease
Movement Disorders·2024· 10 cited
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
npj Parkinson s Disease·2024· 10 citedOpen Access
Key features of an acceptable trial investigating the effects of dual-task training on balance in people with Parkinson’s disease
Physiotherapy·2024
Improving Conversations about Parkinson's Dementia
Movement Disorders Clinical Practice·2024· 2 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

К. Ray Chaudhuri(14), John Zajicek(10), Angelo Antonini(8), Monty Silverdale(7), Alexandra Rizos(6), Per Odin(6), Pablo Martínez‐Martín(6), Joshua Shulman(6), Lynn Rochester(5), Cristian Falup‐Pecurariu(5), Marie‐Louise Zeissler(5), Huw R. Morris(5), Anette Schrag(5), Suvankar Pal(4), B. Kessel(4), Anna Sauerbier(4), Alan Whone(4), Richard Wyse(4), C. Oliver Hanemann(4), Thomas Foltynie(4)